GuideNephrology
Clinical outcomes in CKD with eGFR < 30 (CKD-PC): kidney replacement, cardiovascular event and death
Reading sheet on the CKD Prognosis Consortium models estimating at 2 and 4 years the probability and sequence of kidney replacement therapy, cardiovascular events and death.
Updated 3 November 2026
When to use it
Adults with CKD and eGFR < 30 ml/min/1.73 m² not on dialysis, to give a comprehensive prognosis (not only dialysis risk) and plan vascular access, transplantation or conservative care.
What it is
Models developed from 264,296 people in 30 countries with eGFR < 30 (median eGFR 24 and ACR 168 mg/g), using competing-risk regression, random-effects meta-analysis and Markov processes with Monte Carlo simulation. Hence there is no closed formula that can be reproduced here: results are obtained with the consortium's official calculator.
Keep reading in the app
- Variables
- What it provides
- Limitations
Practical tip
Unlike the KFRE, it accounts for competing risks: in an older patient with cardiovascular disease, death may be more likely than dialysis.
2 more practical tips in the app.
Reference
Official source: Official CKD Prognosis Consortium calculator
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
